AdaptHealth Q2 Revenue Rises 12.7% on Strong Growth
AdaptHealth reported second-quarter financial results, highlighting organic growth, portfolio concentration around core health areas, and a strategic sale of its Diabetes Health business for $235 million.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day